MJ - ETFMG Alternative Harvest ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
35.69
+0.75 (+2.15%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close34.94
Open35.55
Bid0.00 x 900
Ask0.00 x 1000
Day's Range35.01 - 35.91
52 Week Range23.01 - 45.40
Volume1,127,607
Avg. Volume872,268
Net Assets933.16M
NAV35.55
PE Ratio (TTM)N/A
Yield1.58%
YTD Return42.96%
Beta (3Y Monthly)2.37
Expense Ratio (net)0.75%
Inception Date2015-12-03
Trade prices are not sourced from all markets
  • Surprise! The Biggest Marijuana ETF Just Made a Massive Move
    Motley Fool15 hours ago

    Surprise! The Biggest Marijuana ETF Just Made a Massive Move

    Find out what happened -- and how.

  • Barrons.comyesterday

    The Latest ETF Trends

    Forget boring concerns about fee compression and that tired active-versus-passive debate: This year’s InsideETFs conference was all about the big new trends in gold, marijuana, and advice.

  • Benzingayesterday

    National Cannabis Industry Association Comments On Marijuana Banking Hearing In Congress

    Members of the House Financial Services Subcommittee on Financial Institutions and Consumer Protection heard testimony Wednesday from representatives of the financial sector, the cannabis industry, law enforcement and the treasurer of California in support of legislation that would make it easier for banks to work with legal cannabis businesses without fear of federal prosecution. The committee discussed a draft of the Secure and Fair Enforcement (SAFE) Banking Act, which is expected to be introduced in the House of Representatives this month by Rep. Ed Perlmutter (D-CO) and Rep. Denny Heck (D-WA).

  • Benzingayesterday

    European Parliament Votes On Resolution Supporting Medical Marijuana: Here's What It Means

    Earlier this week, the European Parliament passed a resolution recommending nations in the European Union revise their laws around medical marijuana to better support research and patient access. While non-binding, the resolution does seek to incentivize these revisions, similar to the World Health Organization’s recommendation of a rescheduling of cannabis and several of its key components under international drug treaties.

  • 4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019
    Zacksyesterday

    4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019

    Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.

  • MarketWatch2 days ago

    King's College London team to study cannabis-based therapy for dementia symptoms

    A team at King's College London is launching a Phase 2 trial of a cannabis-based therapy for the treatment of certain dementia symptoms, according to a Friday announcement from Alzheimer's Research UK, which will also be funding the study. The therapy, called Sativex, is currently approved in the United Kingdom for the treatment of muscle stiffness and tightness in patients with multiple sclerosis. Sativex is a peppermint-flavored mouth spray that contains tetrahydrocannabinol (THC) and cannabidiol (CBD) in equal proportions. The Phase 2 trial will evaluate its efficacy in treating agitation in people with Alzheimer's disease. "Current treatments for behavioural and psychiatric symptoms of dementia are very limited, and we desperately need to develop alternatives," said Dag Aarsland, the lead researcher on the trial.The ETFMG Alternative Harvest ETF has rallied 14% over the past three months, while the S&P 500 index has edged up 1.5%.

  • Benzinga2 days ago

    The Marijuana ETF Continues To Impress; Could Institutional Interest Be Next?

    Up 40 percent this year, the ETFMG Alternative Harvest ETF (NYSE: MJ) remains one of 2019's most impressive non-leveraged exchange traded funds. MJ recently topped billion in assets under management, though it has slightly pulled back from those levels. “The fund has staged an impressive run from it's Christmas Eve 2018 lows,” said Paul Weisbruch, head of ETF sales and trading at Dallas-based Esposito Securities, in a recent note.

  • Analyzing Canopy Growth’s Q3 Results
    Market Realist2 days ago

    Analyzing Canopy Growth’s Q3 Results

    Analyzing Canopy Growth's Q3 ResultsCanopy Growth’s earningsAt ~8:43 PM EST on February 14, Canopy Growth (CGC) (WEED) reported its third-quarter financial results. The company reported gross revenues of 97.7 million Canadian dollars, which

  • MarketWatch2 days ago

    Canopy Growth revenue beats expectations, revenue rises 283% as it reports earnings

    Canopy Growth Corp. reported that it beat revenue expectations well after the end of the extended session late Thursday. The company reported fiscal third-quarter net losses of C$121 million, or losses of $C0.38 a share, compared with net income of C$11 million, or C$0.01 a share, in the year-ago period. Canopy's fiscal third-quarter losses included a mark-market adjustment of convertible senior notes of C$187.5 million, among other items. Without the adjustment, Canopy logged net income attributable to common stockholders of C$67.6 million. Revenue rose to C$83.1 million from C$9.8 million in the year-ago period. Canopy sold 10,102 kilograms of pot and equivalents during the fiscal third-quarter. Analysts surveyed by FactSet had estimated losses of C$0.11 a share on revenue of C$81.1 million, excluding excise taxes; Canopy was expected by analysts to sell 12,782 kilograms of pot with an average price per gram of C$6.58. A company spokeswoman told MarketWatch it released results late into Thursday evening because it wanted to minimize amount of time and the number of news stories prior to the earnings call Friday morning at 8:30 a.m. Eastern time. For the fiscal fourth quarter, analysts model adjusted losses of C$0.19 a share on revenue of C$118.3 million. Canopy shares closed up 0.2% in the regular session to $46.12. Canopy stock has more than doubled in the past year, with the S&P 500 index rising 2% and the ETFMG Alternative Harvest ETF gaining 5%.

  • Why Marijuana ETFs are on a High in 2019
    Zacks2 days ago

    Why Marijuana ETFs are on a High in 2019

    After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets. Here's why ETFs are riding high this year.

  • InvestorPlace2 days ago

    5 of the Best Thematic ETFs to Consider

    There really is an exchange-traded fund (ETF) for that, whatever "that" is. Or at least there is a very good chance there is an ETF for what was previously an obscure or hard-to-access market segment.These products were once called niche ETFs. Today, thematic ETF is the more politically correct and more appropriate vernacular. Whatever terminology investors choose, there is no denying this universe of funds is growing. Some official lists say there are dozens of thematic ETFs in the U.S., but a case can be made there are hundreds -- and the universe is growing."Thematic investing follows certain social, economic, corporate, demographic, or other themes that are popular in society," according to Fidelity. "The opportunity comes when more people believe in the same themes and investment is driven in the direction of these companies. The shift of capital ultimately could drive superior performance in a thematic portfolio if the companies in the indexes benefit from the business."InvestorPlace - Stock Market News, Stock Advice & Trading TipsThere several traits that the best ETFs of this type share, including first-mover advantage; providing access to compelling, fast-growing niches; and impressive performances. Some thematic ETFs fight a battle to attract enough assets to lure other investors, an often vicious circle, but new data indicate more advisors and investors are willing to nibble at new, small funds. That could pave the way for increased adoption of thematic ETFs. * Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks? Here are some of the best ETFs to consider. Best ETFs: ETFMG Alternative Harvest ETF (MJ)Expense Ratio: 0.75% per year, or $75 on a $10,000 investment.The ETFMG Alternative Harvest ETF (NYSEARCA:MJ) is a prime example of a successful thematic ETF as this fund recently topped $1 billion in assets under management. MJ checks several of the aforementioned boxes, notably first-mover advantage and exposure to a fast-growing theme. In fact, the MJ ETF still has the market for U.S.-listed cannabis ETFs to itself.Of course, there is performance. Sometimes. Year-to-date, MJ is up 38%, but that is after the fund lost almost 22% last year. For ETF investors, MJ is the clear choice for accessing the cannabis boom, which is being facilitated by relaxed regulations at the state level. Marijuana is legal for adult recreational use in several states and more states are considering moves to legalize cannabis for medicinal and/or recreational purposes.Some cash-strapped states see the money states such as California and Colorado are raking in and could look to relax marijuana laws to bolster state coffers. That bodes well for MJ over the long-term. Pacer Benchmark Industrial Real Estate SCTR ETF (INDS)Expense Ratio: 0.6%Some of the best ETFs provide access to the real estate sector and do so in unique fashion. The Pacer Benchmark Industrial Real Estate SCTR ETF (NYSEARCA:INDS) hails from a family of unique, thematic ETFs with real estate exposure. INDS offers exposure to one of the real estate industry's most compelling growth segments.Industrial real estate investment trusts (REITs), including those residing in INDS, own facilities and warehouses used to store goods for the e-commerce boom. Industrial REITs are "important because investing in this space is a roundabout way to play the e-commerce sector without exposure to volatile and expensive retail equities like Amazon, Walmart and more," according to Pacer. * 9 U.S. Stocks That Are Coming to Life Again INDS is beating the largest U.S. REIT ETF by nearly 360 basis points this years and this thematic ETF, which will be one year old in May, does not skimp on yield, as highlighted by a 30-day SEC yield of 3%. Global X Internet of Things ETF (SNSR)Expense Ratio: 0.68%The Internet of Things (IoT) is at the epicenter of scores of everyday functions. Those include development and manufacturing of semiconductors and sensors, integrated products and solutions, and applications serving smart grids, smart homes, connected cars, and the industrial internet, according to Global X.The Global X Internet of Things ETF (NASDAQ:SNSR) is the first ETF to provide dedicated IoT access. This thematic ETF tracks the Indxx Global Internet of Things Thematic Index and holds 50 stocks, most of which are technology names, but there is some healthcare exposure as well.Bolstering the case for SNSR is IoT's myriad consumer and industrial applications. The latter includes cloud computing, robotics and more."In addition to the development of smart transportation systems to support autonomous vehicles, the IoT is expected to improve energy grid efficiency, utilities services, commercial and residential property management, and the overall growth of smart cities," according to Global X research. "The global smart grid market is forecasted to reach $61.3 billion by 2023, up from $23.8 billion in 2018, with a compound annual growth rate (CAGR) of 20.9%." ALPS Disruptive Technologies ETF (DTEC)Expense Ratio: 0.5%Why access just one interesting theme when you can get 10 in one ETF? The ALPS Disruptive Technologies ETF (NYSEARCA:DTEC) does just that, making this thematic fund one of the best ETFs for multi-theme exposure.DTEC equally weights 10 disruptive technological themes, including cloud computing, fintech, healthcare innovation, IoT and mobile payments. This thematic ETF equally weights it components as well, which helps reduce concentration risk while giving investors some benefit of the size factor. * Buy These 5 Stocks to Play the Megatrend of the Century DTEC's strategy is working. This year and over the past year, this thematic ETF is topping the Nasdaq-100 Index by impressive margins. It's also beating the Russell 1000 Growth Index over those periods as well, making it one of the best ETFs for tech investing. ALPS Medical Breakthroughs ETF (SBIO)Expense Ratio: 0.5%Although the healthcare sector is often thought of as a defensive destination, there are plenty of exciting thematic ETFs tracking this space. The ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) is definitely one of those funds.Traditional biotech ETFs focus on large-cap stocks, but SBIO is anything but traditional."Stocks included in the Underlying Index must also sustain an average daily trading volume in excess of $1 million for the 90-day period preceding an Underlying Index reconstitution. Constituents must be able to sustain the monthly rates at which they use shareholder capital ('cash burn rates') for at least 24 months," according to ALPS.SBIO is one of the best ETFs to capitalize on its strategy. Over the past three years, this thematic ETF has beaten the Nasdaq Biotechnology Index by a better than 2-to-1 margin.As of this writing, Todd Shriber did not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 U.S. Stocks That Are Coming to Life Again * The 7 Best Video Game Stocks to Power Up Your Portfolio! * 5 Tips to Become a Better Stock Trader Compare Brokers The post 5 of the Best Thematic ETFs to Consider appeared first on InvestorPlace.

  • Benzinga3 days ago

    California Firm Closes Largest Private Funding Round In US Cannabis Industry

    Flow Kana has closed a $125-million funding round — the largest in the history of U.S. cannabis. The sum boosts Flow Kana’s lifetime raise to $175 million and will drive both the expansion of California’s cannabis supply chain and the adoption of a sustainable agricultural model for decentralized small farms, the company said. “Since our initial investment, Flow Kana has continued to execute on its mission of developing a robust and inclusive California cannabis supply chain,” said Michael Henderson-Cohen, a principal at Gotham Green Partners, which led the investment round.

  • Benzinga3 days ago

    Bulls And Bud Of The Week: Dixie Brands And James Henry

    Broader market action added further downward pressure to cannabis stocks last week, despite a fair amount of good news. Particularly in the edibles space, where Dixie Brands (OTC: DXBRF) announced it entered into a joint venture with Choice Labs, which currently operates two retail locations in Michigan. With this JV in place, Dixie will now be able to bring its products to the Michigan cannabis market, which currently boasts the country’s second-largest patient base.

  • Benzinga3 days ago

    Valentine's Day Gift Ideas: Weed-Infused Products For The Marijuana Connoisseur And Canna-Curious

    A number of companies have introduced cannabis-infused wellness products. "Sexual topicals are a revolutionary approach to cannabis that most people still haven’t heard of, and they work so well — especially for women, because of the uniquely absorptive nature of their genitals," said Mathew Gerson, founder and co-CEO of Foria, a manufacturer of cannabis-infused wellness products. Flowhub, a provider of compliance software, said that during last year's Valentine's Day weekend, there was a 22-percent increase in sales over the previous one.

  • Analysts Revised Canopy Growth’s Q3 Estimates
    Market Realist3 days ago

    Analysts Revised Canopy Growth’s Q3 Estimates

    Analysts Revised Canopy Growth's Q3 EstimatesGetting ready for big earnings Canopy Growth (WEED) (CGC) is scheduled to announce its third-quarter earnings on February 14 after the market closes. The company will hold a conference call on February

  • Benzinga3 days ago

    Survey: Despite Marijuana Legalization, Canada Sees No Change In Number Of Consumers

    Cannabis may have become legal in Canada Oct. 17, 2018, but the country's fourth-quarter National Cannabis Survey showed that roughly the same number of Canadians are lighting up as they did when the drug was illicit. The survey found that in the last three months, 15 percent of Canadians used cannabis. Almost one in five Canadians think they will use cannabis in the next three months.

  • Aphria: Analysts’ Ratings and Target Price in February
    Market Realist3 days ago

    Aphria: Analysts’ Ratings and Target Price in February

    Analysts' Ratings for WEED, TLRY, and APHA in February(Continued from Prior Part)Aphria Aphria (APHA) reported its earnings on January 11. Since then, the stock has risen nearly 30% as of February 12. Aphria has made a significant recovery since it

  • Analysts’ Ratings for WEED, TLRY, and APHA in February
    Market Realist4 days ago

    Analysts’ Ratings for WEED, TLRY, and APHA in February

    Analysts' Ratings for WEED, TLRY, and APHA in FebruaryCannabis stocks Canopy Growth (WEED), Aphria (APHA), and Tilray (TLRY) did well in January. They have mainly held their gains in February. On February 11, Aurora Cannabis (ACB) reported its

  • Newsfile4 days ago

    True Leaf Executes Convertible Security Funding Agreement for Gross Proceeds of $4.5 million

    Vernon, British Columbia--(Newsfile Corp. - February 12, 2019) - True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA) ("True Leaf" or the "Company"), a leading global cannabis and hemp wellness brand for pets, announced today that it has executed a funding agreement (the "Funding Agreement") for the issue of a convertible security for gross proceeds of $4,500,000 (the "Investment") with an entity managed by The Lind Partners, a New York-based institutional ...

  • Benzinga4 days ago

    Scoop: One Of America's Top Pharmaceutical Drug Directories Includes CBD Products For The First Time Ever

    Cannabidiol, or CBD, products are now included in the Prescribers' Digital Reference -- formerly known as the Physicians' Desk Reference -- for the first time ever. The companies are HempMeds and Kannaway, two subsidiaries of Medical Marijuana Inc (OTC: MJNA). Medical Marijuana Inc CEO Stuart Titus told Benzinga the company became the first CBD company to be listed in the Prescribers’ Digital Reference, a book and online database containing drug manufacturers' prescribing information, used by doctors, pharmacists and other health care practitioners across the United States.

  • Aurora Cannabis: Sales Grew, Margins Fell in Q2
    Market Realist4 days ago

    Aurora Cannabis: Sales Grew, Margins Fell in Q2

    Aurora Cannabis: Key Takeaways from Its Q2 Earnings(Continued from Prior Part)Gross margins fell In the second quarter, Aurora Cannabis (ACB) reported nearly 363% YoY (year-over-year) and 83% sequential sales growth. The company reported gross

  • Benzinga5 days ago

    Oregon Aims To Create An Export Market For Marijuana

    The twin goals of the legislation are to address rampant oversupply in Oregon's pot marketplace and pave the way for immediate adoption of interstate commerce once marijuana becomes legal at the federal level. It took more than a year after Oregon legalized pot to create a regulatory structure necessary to actually get the market off the ground, said Donald Morse, a Portland-based consultant for the cannabis industry.

  • Benzinga5 days ago

    States Push To Expand Cannabis Access: Will The Market Follow?

    Interest in recreational cannabis is spreading in the U.S. With voters pushing states for medical and adult use legislation, Vermont became the first to decide the issue at the state capital when the state legislature voted in favor of legalization in 2018. Cannabis stocks began 2019 on the rise, with shares of U.S.-traded companies like Canopy Growth Corp (NYSE: CGC) -- up nearly 60 percent-- and Aurora Cannabis Inc (NYSE: ACB) -- up 30 percent -- making huge gains. 420 Investor’s Alan Brochstein notes a correlation between the two.

  • Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’
    Market Realist5 days ago

    Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’

    Why Aurora Cannabis Calls Itself a 'Medical Company at Heart'Aurora stresses the medical side Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’

  • Green Growth Brands Ended in the Red Last Week
    Market Realist6 days ago

    Green Growth Brands Ended in the Red Last Week

    IIPR, GTBIF, and ITHUF Rose, GGBXF Fell Last Week(Continued from Prior Part)Green Growth BrandsGreen Growth Brands (GGBXF) had an eventful week. The stock witnessed a sharp fall during the week. Aphria (APHA) rejected the company’s hostile bid to